MAPK8 and urinary bladder carcinoma: In addition, either the SP600125 (a JNK inhibitor), or SB203580 (a p38 inhibitor) completely blocked the vitamin K2-induced apoptosis in human bladder cancer T24 cells, suggesting activation of JNK and p38 are required and involved in vitamin K2-induced apoptosis in T24 cells.